Press coverage about Teleflex (NYSE:TFX) has trended somewhat positive on Friday, according to Accern. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Teleflex earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned media coverage about the medical technology company an impact score of 45.6234643802908 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:
- Teleflex Incorporated Announces Public Offering of $500 Million of Senior Notes (finance.yahoo.com)
- Teleflex Incorporated — Moody’s rates Teleflex’s new unsecured notes Ba3 (finance.yahoo.com)
- Teleflex to Present at the 29th Annual Piper Jaffray Healthcare Conference (finance.yahoo.com)
- Piper Jaffray Companies Initiates Coverage on Teleflex Incorporated (TFX) (americanbankingnews.com)
- Teleflex Incorporated (TFX) Receives Average Rating of “Buy” from Analysts (americanbankingnews.com)
Teleflex (TFX) traded up $8.00 during mid-day trading on Friday, reaching $263.44. 356,200 shares of the company’s stock traded hands, compared to its average volume of 260,759. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. Teleflex has a 12-month low of $142.97 and a 12-month high of $266.39. The company has a market capitalization of $11,507.39, a price-to-earnings ratio of 31.58, a price-to-earnings-growth ratio of 2.19 and a beta of 1.05.
Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. Teleflex had a net margin of 12.41% and a return on equity of 16.27%. The firm had revenue of $534.70 million during the quarter, compared to analyst estimates of $522.94 million. During the same quarter in the previous year, the firm earned $1.80 earnings per share. The firm’s revenue for the quarter was up 17.3% compared to the same quarter last year. equities research analysts predict that Teleflex will post 8.34 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Wednesday, November 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.52%. The ex-dividend date is Tuesday, November 14th. Teleflex’s dividend payout ratio (DPR) is 24.82%.
A number of research firms have recently issued reports on TFX. Deutsche Bank AG lowered shares of Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price objective on the stock. in a research note on Tuesday. Piper Jaffray Companies started coverage on shares of Teleflex in a research note on Friday, November 10th. They issued an “overweight” rating and a $295.00 price target for the company. Morgan Stanley lifted their price target on shares of Teleflex from $274.00 to $290.00 and gave the stock an “equal weight” rating in a research note on Friday, November 3rd. Jefferies Group LLC lifted their price target on shares of Teleflex from $270.00 to $295.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Finally, Needham & Company LLC lifted their price target on shares of Teleflex from $237.00 to $285.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. Teleflex presently has a consensus rating of “Hold” and an average price target of $274.44.
TRADEMARK VIOLATION WARNING: This report was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://ledgergazette.com/2017/11/17/teleflex-tfx-receives-news-impact-score-of-0-14.html.
In other news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $211.75, for a total transaction of $42,350.00. Following the completion of the transaction, the director now owns 8,080 shares of the company’s stock, valued at $1,710,940. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In the last three months, insiders have sold 600 shares of company stock valued at $138,162. Corporate insiders own 2.39% of the company’s stock.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.